WO2005117811A2 - Physiological cooling compositions - Google Patents
Physiological cooling compositions Download PDFInfo
- Publication number
- WO2005117811A2 WO2005117811A2 PCT/US2005/013288 US2005013288W WO2005117811A2 WO 2005117811 A2 WO2005117811 A2 WO 2005117811A2 US 2005013288 W US2005013288 W US 2005013288W WO 2005117811 A2 WO2005117811 A2 WO 2005117811A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- carboxamide
- menthyl lactate
- acyclic
- cyclohexane
- Prior art date
Links
- 0 CC(C)[C@]1C(*)CC(C)CC1 Chemical compound CC(C)[C@]1C(*)CC(C)CC1 0.000 description 3
- UJNOLBSYLSYIBM-MMVSWEMESA-N CC(C)[C@H](CCC(C)C1)[C@@H]1OC(C(C)O)=O Chemical compound CC(C)[C@H](CCC(C)C1)[C@@H]1OC(C(C)O)=O UJNOLBSYLSYIBM-MMVSWEMESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
- A23L27/202—Aliphatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
- A23L27/203—Alicyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Definitions
- /-menthol a compound having the structure shown below, and which has been widely used in several of the above mentioned applications.
- /-menthol has an excellent cooling strength, low sensitivity threshold, and is relatively inexpensive compared to other coolant compounds.
- menthol also exhibits several undesirable properties, such as a strong "stinging" smell, a somewhat bitter taste, and it has a relatively high volatility.
- These disadvantages of /-menthol have limited its acceptance for use in various applications and therefore have stimulated intense research for suitable physiological cooling agents that possess a low volatility and exhibit a relatively weak odor or even no odor at all.
- the primary focus of physiological coolant compound research has been toward the synthesis of compounds having a hydrocarbon skeleton similar to menthol, but which also comprise a "heavier" functional group than the hydroxyl functional group of menthol.
- p-MCA One commercially important group of synthetic coolants are the N-substituted 3- p-menthane carboxamides
- N- substituted 3-p-menthane carboxamides p-MCA represent a larger group of cyclohexane carboxamides of the general structure 1:
- Substituents X and Xi as referred to in general structures 1 and 2 above are typically lower linear or branched alkyl groups, such as methyl, ethyl, tertiary butyl; aryl groups such as p-methoxyphenyl; or functionally substituted alkyl groups such as ethoxycarbonylmethyl, and the like.
- Substituents R ls R 2 , R 3 , R ⁇ R 5 , R 6 , R7, Rs, R9, Rio, R 11 , R ⁇ 2 , R ⁇ 3 and R 1 , as used in general structures 1 and 2 above, are typically independently hydrogen atoms, lower linear or branched alkyl groups, such as methyl, ethyl, isopropyl, tertiary butyl, and the like.
- N-ethyl-3-p-menthane carboxamide commonly referred to as WS-3
- WS-23 N,2,3-trimethyl-2-isopropylbutanamide
- a third commercially important class of synthetic physiological cooling agents are /-menthol based esters and ethers, having the general structure:
- substituent Y typically represents a lactic acid residue - OC(0)CH(OH)CH 3 , a monosuccinate residue -OC(0)CH 2 CH 2 COOH, a monoglutarate residue -OC(0)CH 2 CH 2 CH 2 COOH, or a glycerin residue -OCH 2 CH(OH)CH 2 OH, and the like.
- ML menthyl lactate
- MMS monomenthyl succinate
- MMG monomenthyl glutarate
- esters and ethers are weaker cooling agents compared to the above mentioned carboxamides.
- the most commercially important member of the ester/ether class is Menthyl Lactate ML.
- MMS MMG menthone glycerin acetal
- isopulegol sold under the trade name Coolact ® P
- p-menthane-3,8-diol sold under the trade name Coolact ® 38D
- isopulegol sold under the trade name Coolact ® P
- p-menthane-3,8-diol sold under the trade name Coolact ® 38D
- menthyl lactate is also a solid material, although with a relatively lower melting point (see Table 1).
- /-Menthol itself is a solid with a melting point of approximately 40-44 °C.
- MPD MPD, MSS, MMG, MGA, Coolact P ® and Coolact ® 38D
- Table 1 Melting points of commercially important solid cooling agents
- This melting step also raises safety concerns.
- a 25-kg pail of solid WS-3 with a melting point of about 100°C or just below 100°C must be placed in a "hot room,” and heated to a temperature equal to or exceeding 100 °C.
- the hot pail containing melted WS-3 has to be handled by personnel, introducing dangerous opportunities for burn related injuries to occur.
- the coolant is in the form of a free-flowing powder or crystalline form, it can be added to the composition as such.
- blending of a powder or crystalline material can cause inhomogeneity of the final blend.
- the present invention is based, in part, upon physiological cooling compositions comprising at least one cyclohexane carboxamide; at least one acyclic carboxamide; and at least one stereoisomer of menthyl lactate.
- physiological cooling compositions comprising at least one cyclohexane carboxamide; at least one acyclic carboxamide; and at least one stereoisomer of menthyl lactate.
- X and Xi are independently a linear alkyl, a branched allcyl, an aryl, a functionally substituted aryl, an arylalkyl, a functionally substituted arylalkyl, or an alkoxycarbonylalkyl group; and wherein R ⁇ , R 2 , R 3 , R4, R5, R > , R7, R 8 , R°, Rio, R11, R ⁇ 2 , R ⁇ 3 , and R 14 are each independently a hydrogen, a linear alkyl, a branched alkyl, an alkenyl, an alkoxy, an alkoxycarbonyl, or an alkoxycarbonylalkyl group.
- the physiological cooling compositions of the instant invention are capable of existing in a stable liquid form at ambient temperature and atmospheric pressure, even in the substantial absence of a solvent and/or menthol.
- the present invention further provides a method for producing the physiological cooling compositions described herein.
- the method comprises the steps of a) providing at least one cyclohexane carboxamide of the general structure (1), at least one acyclic carboxamide of the general structure (2), and at least one stereoisomer of menthyl lactate of the formula (ML); and b) blending the at least one cyclohexane carboxamide, at least one acyclic carboxamide and at least one stereoisomer of menthyl lactate together under conditions effective to provide a physiological cooling composition as disclosed herein.
- the present invention provides the product produced by the process described herein.
- the present invention also provides a consumer product comprising the physiological cooling compositions described herein.
- alkyl refers to a paraffmic hydrocarbon group which can be derived from an alkane by dropping one or more hydrogen(s) from the formula.
- Non-limiting examples include C ⁇ -C 2 o alkane derivatives such as methyl, ethyl, propyl, isopropyl, butyl, t-butyl, and isobutyl.
- an alkyl substituent suitable for use in the present invention can be a branched or straight chain alkyl substituent.
- the term “lower alkyl” refers to a C ⁇ -C 8 alkyl group as defined above.
- alkenyl is intended to refer to a substituent derived from the class of unsaturated hydrocarbons having one or more double bonds. Those containing only one double bond are referred to as alkenes or alkenyl substituents. Those with two or more double bonds are called alkadienes (alkadienyl), alkatrienes (alkatrienyl) and so on. Non-limiting examples include ethenyl, propenyl, isopropenyl, butenyl, isooctenyl, and the like. To this end, it should be understood that an alkenyl substituent suitable for use in the present invention can be substituted or unsubstituted, including, without limitation, functional substituents.
- aryl refers to a compound or substituent whose molecules have the ring structure characteristic of benzene, naphthalene, phenanthrene, anthracene, and the like. That is to say, an aryl group typically contains either the 6- carbon ring of benzene or the condensed 6 carbon rings of other aromatic derivatives.
- an aryl group can be a phenyl or naphthyl group.
- aryl substituents suitable for use with the present invention can be substituted or unsubstituted, including, without limitation, functional substituents.
- alkoxy refers to a functional group having the general structure -OR; wherein “R” is an alkyl group as defined herein.
- alkoxycarbonyl refers to a functional group having the general structure -(CO)-O-R, wherein “R” is an alkyl group as defined herein.
- alkoxycarbonylalkyl refers to a functional group having the general structure -R-(CO)-0-R, wherein "R” is an alkyl group as defined herein.
- a non-limiting example of the alkoxycarbonylalkyl group is -CH 2 COOC 2 Hs.
- arylalkyl refers to a group comprising an aryl group attached to an alkyl group. It should be understood, that both the alkyl group and the aryl group comprising the arylalkyl group can be substituted or unsubstituted, including, without limitation, functional substituents.
- a non-limiting example of the arylalkyl group is vanillyl group having the formula -CH 2 C 6 H 3 (p-OH)(m-OMe).
- the term or phrase "effective,” “effective amount,” or “conditions effective to” refers to such amount or condition that is capable of performing the function or property for which an effective amount is expressed.
- the exact amount or particular condition required will vary from one embodiment to another, depending on recognized variables such as the materials employed and the processing conditions observed. Thus, it is not always possible to specify an exact “effective amount” or “condition effective to.” However, it should be understood that an appropriate effective amount will be readily determined by one of ordinary skill in the art using only routine experimentation.
- the phrase "functional substituent” or “functionally substituted” refers to substituents including, without limitation, carboxylic acid, acid anhydride, ester, acid halide, alkyl halide, halogen, amide, nitrile, aldehyde, ketone, alcohol or phenol, amine, and ether.
- the present invention provides a physiological cooling composition, comprising a cyclohexane carboxamide; an acyclic carboxamide; and a stereoisomer of menthyl lactate.
- the cyclohexane carboxamide has the general structure (1),
- X is a linear alkyl, a branched alkyl, an aryl, a functionally substituted aryl, an arylalkyl, a functionally substituted arylalkyl, or an alkoxycarbonylalkyl group.
- Ri, R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , Rio, and Rn are each independently a hydrogen, a linear alkyl, a branched alkyl, an alkenyl, an alkoxy, an alkoxycarbonyl, or an alkoxycarbonylalkyl group.
- the cyclohexane carboxamide is N-ethyl-3 -p-menthane carboxamide, commonly known as WS-3 and having the general structure la:
- the cyclohexane carboxamide is N-(ethoxycarbonylmethyl)-3- p-menthane carboxamide, also known as N-[[5-methyl-2-(l-methylethyl)cyclohexyl]- carbonyl]glycine or WS-5, and having the general structure lb:
- the cyclohexane carboxamide lb can be used in substantially pure form or less than substantially pure form.
- substantially pure compound lb can be at least 96% pure, 97% pure, 98% pure, 99% pure, 99% or even essentially 100% or pure form.
- Purification of the impure ethyl ester of N-[[5-methyl-2-(l-methylethyl) cyclohexyl]carbonyl]glycine lb can be performed using general purification methods known in the art for purifying an organic compound, which include, but are not limited to, crystallization, recrystallization, precipitation, redistillation, sublimation, or a combination thereof.
- compound lb can also be used as a mixture of two or more stereoisomers or as practically pure isomers. In one aspect, it is preferred to use the (lR,2S,5R)-isomer, having the structure:
- the cyclohexane carboxamide is N-tert- butyl-3 -p-menthane carboxamide, commonly known as WS-14, and having the structure lc:
- the cyclohexane carboxamide is a derivative of dihydrocyclogeranyl carboxamide having the general structure Id,
- cyclohexane carboxamide of the structure (Id) comprises a mixture of cis- and trans-isomers or it comprises individual cis- and trans-isomers of the structures ld-cis and ld-trans below:
- Suitable methods for obtaining cyclohexane carboxamides of the general formula Id shown above include, without limitation, acid-catalyzed cyclization of geranyl nitrile into cyclogeranyl nitrile, and hydrogenation of the cyclogeranyl nitrile isomers into dihydrocyclogeranyl nitriles followed by a reaction of the dihydrocyclogeranyl nitriles with a suitable alkoxy-containing compound, for example an alkanol (X-OH) in the presence of an acid according to the following scheme:
- isomeric cyclogeranyl nitriles can be first converted to unsaturated cyclogeranyl amides and then hydrogenated to compounds of general formula Id according to the scheme given below.
- Unsaturated cyclogeranyl amides shown on the scheme below also possess cooling activity and can be used instead of their saturated analogs as components of the blends.
- the at least one cyclohexane carboxamide, or mixture of cyclohexane carboxamides is preferably incorporated into the composition in an amount in the range of from about 4% by weight to about 90% by weight of the total physiological coolant composition, inclusive of all weight percentages and ranges therein. Accordingly, the at least one cyclohexane carboxamide can also be present in weight percentage amounts of about 5%, 10%,15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80% or 85% by weight. The at least one cyclohexane carboxamide can also be present in a weight percentage amount in the range of from about 5%, 10%, 15%, 20%,
- the at least one cyclohexane carboxamide can be present in the range of from about 10% by weight to about 80% by weight, or from about
- the acyclic carboxamide comprises N,2,3-trimethyl-2-isopropyl butanamide (also known as 2-(l-methylethyl)-N,2,3-trimethylbutanamide and having a trade name of WS-23) having the structure:
- the acyclic carboxamide according to the invention comprises a compound of the general structure 2b :
- the acyclic carboxamide according to the invention can comprise a compound of the structure 2c commonly known as capsaicin:
- Capsaicin is usually isolated from natural sources, wherein it is often present together with its dihydro derivative dihydrocapsaicin.
- the at least one acyclic carboxamide, or a mixture of acyclic carboxamides is preferably incorporated into the composition in an amount in the range of from about 4% by weight to about 90% by weight of the total physiological coolant composition, inclusive of all weight percentages and ranges therein. Accordingly, the at least one acyclic carboxamide can also be present in weight percentage amounts of about 4%>, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80% or 85% by weight.
- the at least one acyclic carboxamide can also be present in a weight percentage amount in the range of from about 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80% or 85% to about 10%, 15%, 20%, 25%, 30%, 35%>, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85% or 90%.
- the acyclic carboxamide can be present in the range of from about 10%) by weight to about 80% by weight, or from about 20%) by weight to about 70% by weight, or even from about 30% by weight to about 60% by weight.
- compositions of the instant invention further comprise at least one stereoisomer of menthyl lactate, having the general structure (ML):
- the at least one menthyl lactate isomer is the 2S-(lR,2S,5R)-stereoisomer of the following structural formula ML-2S-(1R,2S,5R),
- the at least one menthyl lactate can comprise the ML-2S-(1R,2S,5R) in substantially chemically pure form, or, alternatively, can comprise this stereoisomer in combination with one or more additional stereoisomers of menthyl lactate.
- compositions according to the invention comprise menthyl lactate of the formula ML as a mixture of its stereoisomers, but significantly enriched in the ML-2S- (1R,3R,4S) isomer.
- the at least one menthyl lactate stereoisomer is preferably incorporated into the composition in an amount in the range of from about 4% by weight to about 90% by weight of the total physiological coolant composition, including all weight percentages and ranges therein.
- the menthyl lactate can also be present in weight percentage amounts of about 5%, 10%, 15%, 20%, 25%, 30%), 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80% or 85% by weight.
- the at least one stereoisomer of menthyl lactate can also be present in a weight percentage amount in the range of from about 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80% or 85% to about 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85% or 90%.
- the menthyl lactate can be present in the range of from about 10%) by weight to about 80%> by weight, or from about 20% by weight to about 70% by weight, or even from about 30% by weight to about 60% by weight.
- menthyl lactate is commercially available and can also be readily obtained by a synthesis reaction comprising a direct esterification of lactic acid with menthol followed by an aqueous work-up, as illustrated by the following reaction scheme.
- the physiological coolant compositions of the instant invention can comprise any desired combination of an at least one acyclic carboxamide, at least one cyclohexane carboxamide and at least one stereoisomer of menthyl lactate as disclosed herein.
- the at least one cyclohexane carboxamide comprises N-ethyl-3 -p-menthane carboxamide (WS-3)
- the at least one acyclic carboxamide comprises N,2,3-trimethyl-2-isopropyl butanamide (WS-23)
- the at least one menthyl lactate stereoisomer comprises ML-2S-(1R,2S,5R) stereoisomer of menthyl lactate.
- the physiological cooling compositions of the present invention exist as a stable liquid under normal or ambient conditions.
- normal conditions refers to ambient temperature and atmospheric pressure at any given time.
- ambient temperature is in the range of from approximately 19°C to approximately 25 °C and all temperatures and ranges therein.
- the liquid compositions according to the invention can be used in a spray-dried, co-dried, or microencapsulated form.
- the liquid composition remains a liquid under normal or ambient conditions upon inflicting a mechanical disturbance and/or seeding with crystals or powder of one or more individual components of the composition.
- the physiological cooling compositions of the instant application are substantially solvent free.
- substantially solvent free refers to a physiological coolant composition that exists as a stable liquid under normal conditions irrespective of the presence of a solvent. That is to say that a solvent is not necessary in order for the physiological coolant composition to retain a liquid state under normal conditions.
- substantially solvent free can be a composition having no more than 10%) by weight solvent.
- substantially solvent free can be a composition having less than 5%> by weight solvent, or less than 2%> by weight solvent; or less than 1%> by weight solvent.
- substantially solvent free can include a composition that does not contain any solvent.
- the present invention provides cooling compositions that are free of solvents
- the optional addition of a solvent to the liquid composition according to the invention does not constitute a departure from the invention.
- solvents that can be added include alcohols such as ethyl alcohol and isopropanol, glycols such as propylene glycol and dipropylene glycol, glycerin, esters such as ethyl acetate, isopropyl myristate or triacetin, hydrocarbons such as heptane and petroleum fractions.
- the physiological cooling compositions of the instant invention are substantially menthol free.
- substantially menthol free refers to a physiological coolant composition that does not contain a substantial amount of menthol.
- a substantial amount of menthol is defined in one aspect as an amount that would alter or influence the coolant properties of the composition.
- a substantial amount of menthol is defined as an amount that provides undesirable properties, such as a strong "stinging" smell, a somewhat bitter taste, or increased volatility.
- substantially menthol free refers to a composition comprising an amount of menthol that is less than or equal to about 10% by weight, or less than or equal to about 5% by weight, or less than or equal to about 3% by weight, or less than or equal to 2%> by weight, or less than or equal to 1% by weight, or less than or equal to about 0.5% by weight or even about zero percent by weight.
- the optional addition of menthol to the liquid composition according to the invention does not constitute a departure from the invention.
- menthol can be present as a non-substantial impurity in commercial batches and samples of menthyl lactate.
- a non-substantial impurity in one aspect, is an impurity present in an amount that is less than or equal to about 10%> by weight, less than or equal to about 5% by weight, less than or equal to about 3% by weight, less than or equal to 2%> by weight, less than or equal to 1% by weight, less than or equal to about 0.5%) by weight or even about zero percent by weight. Therefore, in one aspect, the presence of a non-substantial amount of menthol in the composition according to the invention can be reasonably expected. As illustrated by the appended examples, in another aspect, the compositions of the instant application surprisingly provide a synergistic cooling effect, i.e.
- the present invention further provides a method for producing the physiological cooling compositions described herein.
- the method comprises the steps of a) providing at least one cyclohexane carboxamide of the general structure (1), at least one acyclic carboxamide of the general structure (2), and at least one stereoisomer of menthyl lactate of the formula (ML); b) blending the at least one cyclohexane carboxamide, at least one acyclic carboxamide and at least one menthyl lactate together under conditions effective to provide a physiological cooling composition as disclosed herein.
- the conditions effective to provide a physiological cooling composition comprise co-melting and/or kneading the mixture of the cyclohexane carboxamide, acyclic carboxamide and menthyl lactate to provide a liquid physiological cooling composition as disclosed herein.
- the individual components can be melted independently and then blended together in their respective liquid states to provide the physiological cooling composition.
- the compositions of the present invention can be used in any consumer good capable of using a cooling agent.
- the liquid compositions according to the invention are suitable for human consumption.
- the consumer goods are suitable for topical application to mammalian skin, including without limitation, human as well as veterinary applications.
- consumer goods include, without limitation, flavor blends, foods, cosmetic preparations, confectionery, soft and alcoholic beverages, chewing gums, toothpaste, dental floss, mouthwash, anti-plaque, anti-gingivitis compositions, shampoos, antidandruff shampoos, lotions, deodorants, after shave lotions, shaving gels, shaving aid composites, fragrances, skin sanitizing compositions, throat lozenges, throat drops, chewable antacid tablets, or pharmaceutical compositions or medications, including anti- inflammatory compositions, compositions for treatment of nasal symptoms, for upper gastrointestinal tract distress, for treating cold symptoms, for cough relief, for alleviating discomfort of hot flash, or for foot therapy, and the like.
- compositions according to the instant invention can be used in combination with accessory compounds that facilitate the incorporation of the components of the composition into the above mentioned consumer goods.
- accessory compounds include, but are not limited to, solvents such as ethanol or propylene glycol, control release agents or gel-forming agents, such as hydroxyalkyl cellulose or starch, modified starch, and various carriers such as amorphous silica, alumina, or activated carbon.
- solvents such as ethanol or propylene glycol
- control release agents or gel-forming agents such as hydroxyalkyl cellulose or starch, modified starch
- various carriers such as amorphous silica, alumina, or activated carbon.
- aqueous solutions of products for organoleptic tests were obtained by dissolving appropriate amounts of the products in propylene glycol PG and adding the PG solution to an appropriate amount of water.
- Comparative Examples 1-9 Dual mixtures of WS-3 and Menthyl Lactate Mixtures of WS-3 and menthyl lactate were prepared by co-melting given quantities of WS-3 and Menthyl Lactate and allowing them to cool to the ambient temperature in the laboratory (20-25 °C). The mixtures that did not spontaneously solidify were mechanically disturbed (shaken) for 0.5-3 minutes or seeded with WS-3 and/or ML. The results for Examples 1-9 are given in the Table 2 below. Table 2
- Comparative Example 30 A mixture of two cyclohexane carboxamides and Menthyl Lactate in the absence of an acyclic carboxamide
- a mixture of WS-3, menthyl lactate and N,2,2,6-Tetramethylcyclohexane-l- carboxamide was prepared by co-melting 5 g of WS-3, 5 g of Menthyl Lactate and 5 g of N,2,2,6-Tetramethylcyclohexane-l -carboxamide. Upon cooling to the ambient temperature in the lab, the mixture spontaneously solidified.
- Inventive Examples 31-38 Compositions comprising WS-3 as a cyclohexane carboxamide.
- WS-23 as an acyclic carboxamide.
- Inventive Example 39 Application of the kneading method for the preparation of a compositions comprising WS-3 as a cyclohexane carboxamide.
- WS-23 as an acyclic carboxamide
- a mixture of 18 g of WS-3, 18 g of WS-23, and 24 g of ML was kneaded over 12 hours in a rotating flask at room temperature and atmospheric pressure.
- the resulting composition was a clear transparent liquid and contained about 30% of WS-3, about 30%) of WS-23, and about 40% of Menthyl Lactate.
- compositions comprising WS-14 as a cyclohexane carboxamide, WS-23 as an acyclic carboxamide, and ML containing the ML-2S-(1R,2S,5R) stereoisomer
- WS-14, WS-23 and Menthyl Lactate were prepared by co-melting given quantities of WS-14, WS-23 and Menthyl Lactate and allowing them to cool to the ambient temperature in the laboratory (20-25 °C).
- the mixtures that did not spontaneously solidify were mechanically disturbed (shaken) for 0.5-3 minutes and/or seeded with WS-14, WS-23, and/or ML.
- Table 8 Table 8
- Inventive Example 44 Composition comprising WS-5 as a cyclohexane carboxamide.
- WS-23 as an acyclic carboxamide.
- ML containing the ML-2S-(1R,2S.5R) isomer Five grams of highly purified WS-5 (purity 99%>+; melting point about 82 ° C) was co-melted with equal amounts of WS-23 (5 g) and ML (5 g) to give 15 g of a clear transparent liquid composition containing about equal parts by weight of WS-5, of WS- 23, and of Menthyl Lactate.
- composition comprising WS-5 as a cyclohexane carboxamide.
- WS-23 as an acyclic carboxamide.
- ML acyclic carboxamide
- the glyceryl ether of p-menthane-3- carboxylic acid (WS-30)
- composition comprising WS-5 as a cyclohexane carboxamide.
- WS-23 as an acyclic carboxamide.
- ML and an additional component.
- Monomenthyl Glutarate Five grams of highly purified WS-5 (purity 99%+; melting point about 82 ° C) was co-melted with 5 g of WS-23, 5 g of ML, and 5 g of a liquid coolant Monomenthyl Glutarate (MMG) to give 20 g of a clear transparent liquid composition containing about 25% of WS-5, about 25% of WS-23, about 25% of Menthyl Lactate, and about 25% of MMG. After cooling the mixture to room temperature, the composition retained its liquid state upon shaking and upon seeding with WS-5, WS-23 and ML.
- MMG liquid coolant Monomenthyl Glutarate
- Inventive Example 47 Composition comprising WS-5 as a cyclohexane carboxamide, WS-23 as an acyclic carboxamide. ML. and an additional component MPD
- MPD Menthoxy propanediol
- compositions comprising N.2,2,6-Tetramethylcyclohexane-l-carboxamide as a cyclohexane carboxamide.
- WS-23 as an acyclic carboxamide, and ML containing the ML-2S-QR.2S.5R) isomer.
- Composition comprising WS-3 as a cyclohexane carboxamide.
- WS-23 as an acyclic carboxamide.
- Capsaicin as additional acyclic carboxamide.
- Cooling strength values for individual coolants were those generally accepted in the art and also additionally confirmed using expert evaluations conducted by Millennium Specialty Chemicals personnel on the basis of a sequential dilution method, i.e., a controlled dilution of samples to the concentration where their strength is about equal to the standard solution of WS-3.
- a sequential dilution method i.e., a controlled dilution of samples to the concentration where their strength is about equal to the standard solution of WS-3.
- a 10 ppm solution of WS-3 in water was used as the standard solution and was assigned a standardized cooling strength value of 10.0.
- the corresponding relative cooling strengths for the individual cooling agents were then assigned based upon an organoleptic determination of the approximate concentration of cooling agent that was required to provide about the same cooling strength as the standardized 10 ppm solution of WS-3. Accordingly, the following cooling strengths were assigned to the cooling agents as follows: highly purified WS-5 had a relative cooling strength of about 16J; WS-3 was assigned a cooling strength of 10.0; WS-23 had a relative cooling strength of about
- Aqueous solutions were prepared of compositions of coolants obtained in inventive examples 32, 35, 37, 44, 45, and 52. Each solution contained 10 ppm concentration of the total composition.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES05778373T ES2380217T3 (en) | 2004-05-28 | 2005-04-19 | Physiological refrigerant compositions |
MXPA06013389A MXPA06013389A (en) | 2004-05-28 | 2005-04-19 | Physiological cooling compositions. |
AT05778373T ATE541470T1 (en) | 2004-05-28 | 2005-04-19 | PHYSIOLOGICAL COOLING COMPOSITIONS |
JP2007515086A JP2008501017A (en) | 2004-05-28 | 2005-04-19 | Physiological cool composition |
EP05778373A EP1750525B1 (en) | 2004-05-28 | 2005-04-19 | Physiological cooling compositions |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/857,272 | 2004-05-28 | ||
US10/857,272 US7482378B2 (en) | 2004-05-28 | 2004-05-28 | Physiological cooling compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005117811A2 true WO2005117811A2 (en) | 2005-12-15 |
WO2005117811A3 WO2005117811A3 (en) | 2006-05-04 |
Family
ID=35425499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/013288 WO2005117811A2 (en) | 2004-05-28 | 2005-04-19 | Physiological cooling compositions |
Country Status (8)
Country | Link |
---|---|
US (1) | US7482378B2 (en) |
EP (1) | EP1750525B1 (en) |
JP (1) | JP2008501017A (en) |
CN (1) | CN100450474C (en) |
AT (1) | ATE541470T1 (en) |
ES (1) | ES2380217T3 (en) |
MX (1) | MXPA06013389A (en) |
WO (1) | WO2005117811A2 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006116436A1 (en) * | 2005-04-28 | 2006-11-02 | The Procter & Gamble Company | Dental floss compositions comprising menthol and carboxamides |
EP1958627A2 (en) | 2007-01-04 | 2008-08-20 | Symrise GmbH & Co. KG | Use of certain menthyl-3-oxocarbonic acid esters as physiological cooling agents |
US20130156885A1 (en) * | 2010-06-18 | 2013-06-20 | Sonya S. Johnson | Chewing gum containing combinations of physiological cooling agents |
US20130177669A1 (en) * | 2010-06-18 | 2013-07-11 | Wm. Wrigley Jr. Company | Chewing gum products containing ethyl ester of n-[[5-methyl-2-(1-methylethyl)-cyclohexyl] carbonyl] glycine |
WO2017058739A3 (en) * | 2015-09-30 | 2017-08-03 | Wm. Wrigley Jr. Company | Cooling formulations |
US11183564B2 (en) | 2018-06-21 | 2021-11-23 | Intel Corporation | Quantum dot devices with strain control |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070107747A1 (en) * | 2001-12-04 | 2007-05-17 | Whitehill Oral Technologies, Inc. | Cleaning perception oral care products |
US20060177384A1 (en) * | 2001-12-04 | 2006-08-10 | Brown Dale G | Sialagogue coatings for interproximal devices |
US20070148284A1 (en) | 2004-08-25 | 2007-06-28 | Cadbury Adams Usa Llc. | Liquid-filled chewing gum |
US7767243B2 (en) * | 2004-12-29 | 2010-08-03 | WH. Wrigley Jr. Company | Combinations of cooling agents for use in confections |
AU2006306563B2 (en) * | 2005-01-04 | 2009-10-01 | Teikoku Pharma Usa, Inc. | Topical pain relief compositions of N,2,3-trimethyl-2-isopropylbutamide and methods for using the same |
CA2591867C (en) | 2005-01-04 | 2010-12-14 | Teikoku Pharma Usa, Inc. | Cooling topical patch preparation |
CN101282707B (en) * | 2005-10-05 | 2013-03-27 | 卡夫食品环球品牌有限责任公司 | Cooling compositions including menthyl esters |
US20070221236A1 (en) * | 2005-10-05 | 2007-09-27 | Cadbury Adams Usa Llc. | Cooling compositions including menthyl esters |
US20070148283A1 (en) * | 2005-12-23 | 2007-06-28 | Cadbury Adams Usa Llc | Compositions providing a sensation substantially similar to that provided by menthol |
US20070178123A1 (en) * | 2006-01-27 | 2007-08-02 | Deborah Levenson | Flavor-enhancing compositions, method of manufacture, and methods of use |
WO2007127674A2 (en) * | 2006-04-26 | 2007-11-08 | Whitehill Oral Technologies, Inc. | Methods for coating dental devices with dry-to-the touch saliva soluble flavors |
JP4728428B2 (en) * | 2006-09-27 | 2011-07-20 | キャドバリー アダムス ユーエスエー エルエルシー | Cold confectionery and beverages |
US20080213440A1 (en) | 2007-03-01 | 2008-09-04 | Cadbury Adams Usa Llc | Non-Aldehyde Cinnamon Flavor and Delivery Systems Therefor |
US20090110656A1 (en) * | 2007-10-31 | 2009-04-30 | Lemke Sarah A | Skin cooling composition |
JP5660898B2 (en) * | 2007-11-09 | 2015-01-28 | ユニバーシティ オブ テネシー リサーチ ファウンデーション | Anti-inflammatory quinic acid derivatives for oral administration |
US20090142443A1 (en) * | 2007-11-29 | 2009-06-04 | Cadbury Adams Usa Llc | Multi-region chewing gum with actives |
US7662576B2 (en) * | 2007-12-06 | 2010-02-16 | International Flavors & Fragrances Inc. | Method for identifying ester coolers |
US20090157153A1 (en) * | 2007-12-13 | 2009-06-18 | Sarah Anne Lemke | Skin cooling system |
JP2011506589A (en) * | 2007-12-21 | 2011-03-03 | ウェイ,エドワード,タク | P-Mentane-3-carboxylic acid ester for treating airway diseases |
RU2492695C2 (en) | 2008-02-27 | 2013-09-20 | КРАФТ ФУДЗ ГЛОБАЛ БРЭНДЗ ЭлЭлСи | Multizonal confectionary product |
CN102083321A (en) | 2008-05-02 | 2011-06-01 | 吉百利亚当斯美国有限责任公司 | Sugar free isomalt confectionery and methods of making same |
EP2296759B1 (en) * | 2008-05-22 | 2019-10-02 | Givaudan SA | Cooling composition |
AU2010206706C1 (en) | 2009-01-22 | 2015-09-10 | Intercontinental Great Brands Llc | Confectionery processing |
US20110070329A1 (en) * | 2009-09-18 | 2011-03-24 | Arkadiusz Kazimierski | 1-tert-Butylcyclohexanecarboxamide and uses thereof as cooling compounds |
JP5547291B2 (en) | 2009-10-08 | 2014-07-09 | インターコンチネンタル グレート ブランズ エルエルシー | Co-extruded layered candy and gum apparatus and method |
PL2316279T3 (en) | 2009-10-30 | 2014-03-31 | Intercontinental Great Brands Llc | Sugar free confectionery; methods of making same; and use in preparing multilayered confectionery. |
EP3417714B1 (en) | 2009-12-21 | 2019-06-19 | Intercontinental Great Brands LLC | Particulate coating compositions, coated confectionery, and methods of making the same |
EP2584911A1 (en) | 2010-06-25 | 2013-05-01 | Kraft Foods Global Brands LLC | Enhanced release of lipophilic ingredients from chewing gum with hydrocolloids |
EP2457554A1 (en) * | 2010-11-24 | 2012-05-30 | Symrise AG | Mixture containing menthol |
RU2598644C2 (en) * | 2010-12-06 | 2016-09-27 | Альвеоникс Аг | Isopropyl ester of [(1r,2s,5r)-2-isopropyl-5-methylcyclohexanecarbonyl)-amino]-acetic acid, related compounds and use thereof in therapy |
CN103379829B (en) | 2011-02-14 | 2016-03-30 | 洲际大品牌有限责任公司 | There are the confectionery of multiple local flavor and quality |
EP2677878B1 (en) | 2011-02-23 | 2016-02-17 | Intercontinental Great Brands LLC | Flavor pre-blends for chewing gum, methods of making flavor pre-blends and chewing gum compositions thereof |
BR112013022712A2 (en) | 2011-03-11 | 2016-08-09 | Intercontinental Great Brands Llc | system and method of forming multi-layer confectionery |
US9480633B2 (en) | 2011-04-28 | 2016-11-01 | Kimberly-Clark Worldwide, Inc. | Temperature management composition |
US11122815B2 (en) | 2011-07-21 | 2021-09-21 | Intercontinental Great Brands Llc | System and method for forming and cooling chewing gum |
US9675699B2 (en) | 2011-12-22 | 2017-06-13 | International Flavors & Fragrances Inc. | Cooling enhancing compositions |
JP2013195289A (en) | 2012-03-21 | 2013-09-30 | Takasago Internatl Corp | Method for evaluating sense stimulating component |
JP6085901B2 (en) * | 2012-04-16 | 2017-03-01 | 味の素株式会社 | Cool sensation composition |
WO2014007936A1 (en) | 2012-06-19 | 2014-01-09 | Intercontinental Great Brands Llc | Bulk packaged, uncoated chewing gum |
CN102716043B (en) * | 2012-06-29 | 2014-06-18 | 金红叶纸业集团有限公司 | Cool and refreshing emulsion and moist towelette |
CN104582500A (en) | 2012-08-22 | 2015-04-29 | 洲际大品牌有限责任公司 | Chewing gum compositions and methods of making thereof |
WO2014128566A2 (en) | 2013-02-21 | 2014-08-28 | Mondelez International | Chewing gum and methods of making thereof field |
MX369928B (en) | 2013-03-29 | 2019-11-26 | Intercontinental Great Brands Llc | Transparent and transluscent liquid filled candy; process of making thereof; sugar-free liquid edible composition; and use thereof. |
JP6148892B2 (en) * | 2013-04-12 | 2017-06-14 | 三栄源エフ・エフ・アイ株式会社 | High concentration ethyl-2- (p-menthane-3-carboxamide) acetate-containing powder flavor preparation |
US20160100606A1 (en) | 2013-05-31 | 2016-04-14 | Intercontinental Great Brands Llc | Chewing gum with hard, amorphous inclusions; and methods of making thereof |
WO2015051056A1 (en) | 2013-10-02 | 2015-04-09 | Intercontinental Great Brands Llc | Particulate coated chewing gum and confectionery; and methods of making the same |
CN111493194A (en) | 2014-02-28 | 2020-08-07 | 洲际大品牌有限责任公司 | Coating for edible cores, systems, methods and coated products thereof |
RU2657021C2 (en) | 2014-03-03 | 2018-06-08 | Интерконтинентал Грейт Брендс Ллк | Method of producing food product |
US20170079304A1 (en) | 2014-05-15 | 2017-03-23 | Intercontinental Great Brands Llc | Multi-textured chewing gum and methods of making thereof |
WO2016197000A1 (en) | 2015-06-04 | 2016-12-08 | P2 Science, Inc. | Olfactive compositions comprising cyclohexyl-alkyl carbinols |
ES2922649T3 (en) | 2017-01-10 | 2022-09-19 | Takasago Perfumery Co Ltd | Derivative of methylmenthol and composition that confers a sensation of freshness that it contains |
MX2019008796A (en) | 2017-02-06 | 2019-09-26 | Intercontinental Great Brands Llc | Dual-textured confectionery; and methods of making the same. |
GB201703136D0 (en) * | 2017-02-27 | 2017-04-12 | Givaudan Sa | Compositions |
ES2874142T3 (en) | 2017-06-05 | 2021-11-04 | Intercontinental Great Brands Llc | Chewing gum compositions and methods of preparing them |
DK3668326T3 (en) | 2017-08-18 | 2024-01-08 | Perfetti Van Melle Benelux B V | Chewing gum compositions and methods of making the same |
JP7157072B2 (en) * | 2017-10-16 | 2022-10-19 | 高砂香料工業株式会社 | Cooling agent composition containing 2,2,6-trimethylcyclohexanecarboxylic acid derivative |
CN112867400A (en) | 2018-10-26 | 2021-05-28 | 洲际大品牌有限责任公司 | Center-filled confectionery products, coated products and methods of making |
CN109431871A (en) * | 2018-12-25 | 2019-03-08 | 安徽爱迪香料股份有限公司 | A kind of preparation method for the long-acting refrigerant preparation making an addition to the cool cream of external application |
JP6603002B1 (en) * | 2019-06-04 | 2019-11-06 | アサヒ飲料株式会社 | Sugar-free carbonated beverage, method for improving aftercut of cooling substance, and agent for improving aftercut of cooling substance |
AU2020327947B2 (en) | 2019-08-14 | 2023-11-23 | Intercontinental Great Brands Llc | Confectionery chip product; and methods of making the same |
CN112322385A (en) * | 2020-09-14 | 2021-02-05 | 丽水市天博生物科技有限公司 | Mint essence with lasting cool feeling release function and preparation method thereof |
CN116322343A (en) | 2020-10-09 | 2023-06-23 | 洲际大品牌有限责任公司 | Uncoated hard candy product, isomalt confectionery, method of making and use thereof |
WO2023248187A1 (en) | 2022-06-24 | 2023-12-28 | Nicoventures Trading Limited | Oral composition comprising a receptor modulator |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2205255A1 (en) | 1971-02-04 | 1972-11-30 | ||
DE2317538A1 (en) | 1972-04-18 | 1973-10-31 | Wilkinson Sword Ltd | OBJECT OR AGENT WITH THE COLD RECEPTORS OF THE HUMAN NERVOUS SYSTEM STIMULATING EFFECT |
GB1421744A (en) | 1972-04-18 | 1976-01-21 | Wilkinson Sword Ltd | Aliphatic n-substituted tertiary amides possessing physiological cooling activity |
US4150052A (en) | 1971-02-04 | 1979-04-17 | Wilkinson Sword Limited | N-substituted paramenthane carboxamides |
US4178459A (en) | 1971-02-04 | 1979-12-11 | Wilkinson Sword Limited | N-Substituted paramenthane carboxamides |
US4193936A (en) | 1971-02-04 | 1980-03-18 | Wilkinson Sword Limited | N-substituted paramenthane carboxamides |
US4226988A (en) | 1971-02-04 | 1980-10-07 | Wilkinson Sword Limited | N-substituted paramenthane carboxamides |
US6303817B1 (en) | 2000-08-10 | 2001-10-16 | International Flavors & Fragrances Inc. | Method for making amides |
US6482983B1 (en) | 2001-07-31 | 2002-11-19 | Millennium Specialty Chemicals | Process for obtaining N-monosubstituted amides |
US20040018954A1 (en) | 2002-07-24 | 2004-01-29 | Su Evelyn G. | Composition of menthol and menthyl lactate, its preparation method and its applications as a cooling agent |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1422998A (en) | 1973-03-22 | 1976-01-28 | Wilkinson Sword Ltd | Cyclohexanecarboxamides having a physiological cooling effect and compositions containing them |
AU4116993A (en) * | 1992-05-18 | 1993-12-13 | Procter & Gamble Company, The | Coolant compositions |
BR9306575A (en) * | 1992-06-17 | 1998-12-08 | Procter & Gamble | Refreshing compositions with reduced burning |
US5843466A (en) * | 1995-08-29 | 1998-12-01 | V. Mane Fils S.A. | Coolant compositions |
US6550474B1 (en) | 1997-01-29 | 2003-04-22 | Cns, Inc. | Microencapsulated fragrances and methods of coating microcapsules |
GB9707977D0 (en) | 1997-04-21 | 1997-06-11 | Procter & Gamble | Centre filled confectionery |
GB9707979D0 (en) | 1997-04-21 | 1997-06-11 | Procter & Gamble | Confectionery compositions |
GB9707978D0 (en) | 1997-04-21 | 1997-06-11 | Procter & Gamble | Throat soothing compositions |
US6627233B1 (en) * | 1997-09-18 | 2003-09-30 | Wm. Wrigley Jr. Company | Chewing gum containing physiological cooling agents |
US6350438B1 (en) | 1998-02-27 | 2002-02-26 | The Procter & Gamble Company | Oral care compositions comprising chlorite and methods |
US5993836A (en) * | 1998-04-28 | 1999-11-30 | Castillo; James G. | Topical anesthetic formulation |
US6319513B1 (en) | 1998-08-24 | 2001-11-20 | The Procter & Gamble Company | Oral liquid mucoadhesive compounds |
US20020009478A1 (en) | 1998-08-24 | 2002-01-24 | Douglas Joseph Dobrozsi | Oral liquid mucoadhesive compositions |
US6344218B1 (en) | 1998-11-23 | 2002-02-05 | The Procter & Gamble Company | Skin deodorizing and santizing compositions |
US6355706B1 (en) | 1999-04-14 | 2002-03-12 | The Procter & Gamble Company | Denture adhesives with mixed salt copolymers of terpolymers |
US6475498B1 (en) | 1999-12-08 | 2002-11-05 | The Procter & Gamble Company | Method to inhibit tartar and stain using denture adhesive compositions |
US6475497B1 (en) | 1999-12-08 | 2002-11-05 | The Procter & Gamble Company | Tartar control denture adhesive compositions |
US6649178B2 (en) | 2000-06-13 | 2003-11-18 | Fatemeh Mohammadi | Cosmetic composition for stressed skin under extreme conditions |
US6391886B1 (en) | 2000-12-04 | 2002-05-21 | The Procter & Gamble Company | Oral compositions having improved consumer aesthetics |
US7087255B2 (en) | 2000-12-27 | 2006-08-08 | Wm. Wrigley Jr. Company | Chewing gums that provide breath freshening characteristics |
US6500406B1 (en) | 2001-03-19 | 2002-12-31 | The Procter & Gamble Company | Denture care compositions and kits |
US6509007B2 (en) | 2001-03-19 | 2003-01-21 | The Procter & Gamble Company | Oral care kits and compositions |
US20040082654A1 (en) * | 2001-04-17 | 2004-04-29 | The Procter & Gamble Company | Cooling compositons |
WO2002092037A1 (en) | 2001-05-15 | 2002-11-21 | The Procter & Gamble Company | Oral care confectionery compositions |
WO2002091848A1 (en) | 2001-05-15 | 2002-11-21 | The Procter & Gamble Company | Confectionery compositions |
EP1556332B1 (en) | 2002-10-28 | 2016-10-05 | Givaudan SA | Coolant solutions and compositions comprising the same |
-
2004
- 2004-05-28 US US10/857,272 patent/US7482378B2/en active Active
-
2005
- 2005-04-19 WO PCT/US2005/013288 patent/WO2005117811A2/en not_active Application Discontinuation
- 2005-04-19 CN CNB2005800173885A patent/CN100450474C/en not_active Expired - Fee Related
- 2005-04-19 MX MXPA06013389A patent/MXPA06013389A/en active IP Right Grant
- 2005-04-19 JP JP2007515086A patent/JP2008501017A/en active Pending
- 2005-04-19 EP EP05778373A patent/EP1750525B1/en not_active Not-in-force
- 2005-04-19 AT AT05778373T patent/ATE541470T1/en active
- 2005-04-19 ES ES05778373T patent/ES2380217T3/en active Active
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4193936A (en) | 1971-02-04 | 1980-03-18 | Wilkinson Sword Limited | N-substituted paramenthane carboxamides |
US4226988A (en) | 1971-02-04 | 1980-10-07 | Wilkinson Sword Limited | N-substituted paramenthane carboxamides |
GB1351761A (en) | 1971-02-04 | 1974-05-01 | Wilkinson Sword Ltd | Substituted p-menthane carboxamides and compositions containing them |
DE2205255A1 (en) | 1971-02-04 | 1972-11-30 | ||
US4150052A (en) | 1971-02-04 | 1979-04-17 | Wilkinson Sword Limited | N-substituted paramenthane carboxamides |
US4178459A (en) | 1971-02-04 | 1979-12-11 | Wilkinson Sword Limited | N-Substituted paramenthane carboxamides |
GB1421744A (en) | 1972-04-18 | 1976-01-21 | Wilkinson Sword Ltd | Aliphatic n-substituted tertiary amides possessing physiological cooling activity |
DE2317538A1 (en) | 1972-04-18 | 1973-10-31 | Wilkinson Sword Ltd | OBJECT OR AGENT WITH THE COLD RECEPTORS OF THE HUMAN NERVOUS SYSTEM STIMULATING EFFECT |
US4230688A (en) | 1972-04-18 | 1980-10-28 | Wilkinson Sword Limited | Acyclic carboxamides having a physiological cooling effect |
US6303817B1 (en) | 2000-08-10 | 2001-10-16 | International Flavors & Fragrances Inc. | Method for making amides |
US6482983B1 (en) | 2001-07-31 | 2002-11-19 | Millennium Specialty Chemicals | Process for obtaining N-monosubstituted amides |
WO2003011816A1 (en) | 2001-07-31 | 2003-02-13 | Millennium Specialty Chemicals, Inc. | Process for obtaining n-monosubstituted amides |
US20040018954A1 (en) | 2002-07-24 | 2004-01-29 | Su Evelyn G. | Composition of menthol and menthyl lactate, its preparation method and its applications as a cooling agent |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006116436A1 (en) * | 2005-04-28 | 2006-11-02 | The Procter & Gamble Company | Dental floss compositions comprising menthol and carboxamides |
EP1958627A2 (en) | 2007-01-04 | 2008-08-20 | Symrise GmbH & Co. KG | Use of certain menthyl-3-oxocarbonic acid esters as physiological cooling agents |
US20130156885A1 (en) * | 2010-06-18 | 2013-06-20 | Sonya S. Johnson | Chewing gum containing combinations of physiological cooling agents |
US20130177669A1 (en) * | 2010-06-18 | 2013-07-11 | Wm. Wrigley Jr. Company | Chewing gum products containing ethyl ester of n-[[5-methyl-2-(1-methylethyl)-cyclohexyl] carbonyl] glycine |
WO2017058739A3 (en) * | 2015-09-30 | 2017-08-03 | Wm. Wrigley Jr. Company | Cooling formulations |
US11183564B2 (en) | 2018-06-21 | 2021-11-23 | Intel Corporation | Quantum dot devices with strain control |
Also Published As
Publication number | Publication date |
---|---|
EP1750525A2 (en) | 2007-02-14 |
CN1960644A (en) | 2007-05-09 |
MXPA06013389A (en) | 2007-03-01 |
ES2380217T3 (en) | 2012-05-09 |
WO2005117811A3 (en) | 2006-05-04 |
CN100450474C (en) | 2009-01-14 |
US7482378B2 (en) | 2009-01-27 |
US20050265930A1 (en) | 2005-12-01 |
EP1750525B1 (en) | 2012-01-18 |
JP2008501017A (en) | 2008-01-17 |
ATE541470T1 (en) | 2012-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7482378B2 (en) | Physiological cooling compositions | |
AU2018208180B2 (en) | Methylmenthol derivative and cool-sensation imparter composition containing same | |
JP4680986B2 (en) | Physiological cooling composition comprising highly purified ethyl ester of N-[[5-methyl-2- (1-methylethyl) cyclohexyl] carbonyl] glycine | |
ES2395682T3 (en) | Oxalic acid derivatives and their use as physiological refreshing active ingredients | |
EP2064959B1 (en) | Aromatic Neomenthylamides as flavouring agents | |
JP5698120B2 (en) | Warm composition | |
EP1927587B1 (en) | Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof | |
JP2010513657A (en) | N-substituted-p-menthane-3-carboxamides and uses thereof | |
EP2763554B1 (en) | Novel substituted cyclohexane compounds | |
US20080000614A1 (en) | Hot flavor and skin sensation composition | |
US8007840B2 (en) | Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof | |
Leffingwell | 65 Cooling Ingredients and Their Mechanism of Action | |
EP3303281B1 (en) | Physiological cooling compounds | |
DE10227734A1 (en) | New 4-alkoxy- or -alkenyloxy-methyl-2-methoxyphenyl esters have a tingling effect on the skin and are used in aromatizing or taste improving agents for use e.g. with food, toothpastes or pharmaceutical preparations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 3051/KOLNP/2006 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2006/013389 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005778373 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007515086 Country of ref document: JP Ref document number: 200580017388.5 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWP | Wipo information: published in national office |
Ref document number: 2005778373 Country of ref document: EP |